Group 1: Investor Relations Activities - The company conducted a specific object research activity on May 28, 2025, at its facility in Shanghai, attended by various investment firms and individual investors [3] - Key personnel from the company included the Chairman and General Manager, Mr. Wang Binhui, and the Vice General Manager and CFO, Mr. Xie Zhenhua [3] Group 2: Equipment and Supply Chain - The current international trade situation has minimal impact on the company's equipment procurement, with a well-established reserve of critical production equipment [4] - The company utilizes a range of foreign brands for precision machining equipment, including Mazak, DMG, Fanuc, Citizen, and TSUGAMI, covering all categories of turning and milling equipment [4] - Future plans include a gradual establishment of a composite supply chain system, focusing on domestic equipment technology upgrades [4] Group 3: Business Development Strategy - The company maintains a balanced approach to domestic and international sales, with both segments accounting for approximately 50% each [4] - Strategic growth areas include semiconductors, scientific instruments, medical devices, aerospace, and automotive sectors, with a focus on enhancing production efficiency and reducing costs [4][5] - The company is actively pursuing a global strategy, particularly in Europe, to enhance international competitiveness and operational efficiency [5] Group 4: Strategic Partnerships - In April 2024, the company established a strategic partnership with a specialized surface treatment supplier to enhance product quality and supply chain stability [5] - A dedicated production line was set up with the supplier, supported by experienced technical personnel from the company to ensure compliance with technical standards [5] Group 5: Technical Requirements Across Industries - The company’s components serve various downstream industries, each with distinct technical requirements: - Scientific instruments demand high precision, complex structures, and strict quality control [6] - Medical devices share similarities with scientific instruments but require rigorous testing and certification [6] - Transportation products necessitate high precision and complex processing capabilities for mass production [6] - Semiconductor equipment components require high precision, reliability, and stringent cleanliness standards [6]

Core Viewpoint - The Beijing Stock Exchange and China Securities Index Co., Ltd. announced a regular adjustment of the sample stocks and reserve list for the Bei Zheng 50 Index (899050), effective June 16, 2025 [1] Group 1: Sample Stocks - The Bei Zheng 50 Index (899050) includes a total of 50 sample stocks, with notable companies such as: - Nuo Si Lan De (430047) - Hua Ling Co., Ltd. (430139) - Su Zhou Axle Co., Ltd. (430418) - Feng Guang Precision (430510) - An Da Technology (830809) [2] - Additional companies in the index include: - Sen Xuan Pharmaceutical (830946) - Chuang Yuan Xin Ke (831961) - Ao Di Wei (832491) - Na Ke Nuo Er (832522) - De Yuan Pharmaceutical (832735) [2][3] Group 2: Reserve List - The reserve list for the Bei Zheng 50 Index (899050) includes: - Jia Xian Co., Ltd. (920489) - Lei Shen Technology (872190) - Hui Feng Diamond (839725) - Lian Di Information (839790) - Yun Li Wu Li (872374) [3]

上海阿为特精密机械股份有限公司 证券代码：873693 证券简称：阿为特 公告编号：2025-043 关于使用闲置自有资金进行现金管理的进展公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 授权委托理财情况 （一）审议情况 上海阿为特精密机械股份有限公司（以下简称"公司"）于 2025 年 4 月 16 日召开第三届董事会第十次会议、第三届监事会第八次会议，审议通过《关于公 司使用闲置自有资金购买理财产品的议案》，以及于 2025 年 5 月 8 日召开 2024 年年度股东会，审议通过了《关于公司使用闲置自有资金购买理财产品的议案》。 公司拟使用总额不超过人民币 8,000 万元的闲置自有资金购买安全性高的理财 产品，在任意一天持有的理财产品总额不超过人民币 8,000 万元（仅本金，不含 投资收益），在上述额度内，资金可以循环滚动使用。在额度范围内由董事会授 权公司法定代表人行使相关决策权并签署有关法律文件，具体投资活动由公司财 务负责人组织实施。自公司 2024 年年度股东会审议通过之日 ...

天禾（上海）律师事务所 关于上海阿为特精密机械股份有限公司 2024年年度股东会之 法律意见书 地址：中国上海市普陀区云岭东路 89 号长风国际大厦 2001-2003 室 电话:(021) 62119256 关于上海阿为特精密机械股份有限公司 2024年年度股东会之 法律意见书 致:上海阿为特精密机械股份有限公司 天禾(上海)律师事务所(以下简称本所)受上海阿为特精密机械股份有限 公司(以下简称公司)的委托,指派汪东律师、赵紫琼律师(以下简称本所律师) 出席了公司召开的2024年年度股东会(以下简称本次股东会),根据《中华人民 共和国公司法》(以下简称《公司法》)、《中华人民共和国证券法》(以下简称《证 券法》)、中国证券监督管理委员会(以下简称中国证监会)发布的《上市公司股 东会规则》(以下简称《股东会规则》)和北京证券交易所发布的《北京证券交易 所股票上市规则》(以下简称《上市规则》)等法律、法规、规范性文件,以及现 行有效的《上海阿为特精密机械股份有限公司章程》(以下简称《公司章程》)等 规定,就本次股东会的召集、召开程序、出席会议人员资格、召集人资格、会议 的表决程序、表决结果等事宜出具法律意见书。 ...

证券代码：873693 证券简称：阿为特 公告编号：2025-041 上海阿为特精密机械股份有限公司 2024 年年度股东会决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2025 年 5 月 8 日 2.会议召开地点：上海市宝山区宝安公路 917 号 1 幢三楼公司会议室 3.会议召开方式：现场投票和网络投票相结合方式 4.会议召集人：董事会 5.会议主持人：汪彬慧 6.召开情况合法、合规、合章程性说明： 公司本次股东会的召集人资格及召集程序等相关事项符合《公司法》等法律 法规及《公司章程》的规定。 （二）会议出席情况 出席和授权出席本次股东会的股东共 3 人，持有表决权的股份总数 50,400,130 股，占公司有表决权股份总数的 69.3262%。 其中通过网络投票参与本次股东会的股东共 1 人，持有表决权的股份总数 130 股，占公司有表决权股份总数的 0.0002%。 （三）公司董事、监事、高级管理人员出席或列席股东会情况 ...

证券代码：873693 证券简称：阿为特 公告编号：2025-040 上海阿为特精密机械股份有限公司 投资者关系活动记录表 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 投资者关系活动类别 □特定对象调研 □媒体采访 □现场参观 □新闻发布会 □分析师会议 □路演活动 □其他 二、 投资者关系活动情况 活动时间：2025 年 4 月 28 日 活动地点： 中证网"中证路演中心" （https://rs.cs.com.cn/dist/#/index?id=f815aa7ee8d1d877c8f694dd318124 46） √业绩说明会 参会单位及人员：通过网络方式参加公司 2024 年年度报告业绩说明会的投 资者。 上市公司接待人员：公司董事长、总经理：汪彬慧先生；公司董事、副总经 理、董事会秘书、财务负责人：谢振华先生；公司保荐代表人：陈杏根先生、谢 敬涛先生。 三、 投资者关系活动主要内容 公司在 2024 年年度业绩说明会上就投资者普遍关注的问题进行了沟通与交 流，主要问题及回复情况如下： ...

证券代码：873693 证券简称：阿为特 公告编号：2025-039 上海阿为特精密机械股份有限公司 第三届监事会第九次会议决议公告 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2025 年 4 月 24 日 2.会议召开地点：上海市宝山区宝安公路 917 号 1 幢三楼公司会议室 3.会议召开方式：现场 4.发出监事会会议通知的时间和方式：2025 年 4 月 19 日以书面及通讯方式发出 5.会议主持人：监事会主席郑六七先生 （二）会议出席情况 会议应出席监事 3 人，出席和授权出席监事 3 人。 二、议案审议情况 （一）审议通过《关于 2025 年一季度报告的议案》 1.议案内容： 根据《中华人民共和国公司法》《中华人民共和国证券法》《公司章程》等相 关规定，公司编制了《2025 年一季度报告》。具体内容详见公司同日在北京证券 交易所信息披露平台（http://www.bse.cn/）披露的《2025 年一季度报告》（公 告编号：2 ...

证券代码：873693 证券简称：阿为特 公告编号：2025-038 上海阿为特精密机械股份有限公司 第三届董事会第十一次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2025 年 4 月 24 日 2.会议召开地点：上海市宝山区宝安公路 917 号 1 幢三楼公司会议室 3.会议召开方式：现场 4.发出董事会会议通知的时间和方式：2025 年 4 月 19 日以书面及通讯方式 发出 5.会议主持人：汪彬慧先生 6.会议列席人员：全体监事 2.议案表决结果：同意 7 票；反对 0 票；弃权 0 票。 本议案已经 2025 年 4 月 23 日第三届董事会审计委员会第八次会议审议通过。 3.回避表决情况： 7.召开情况合法、合规、合章程性说明： 本次会议的召集、召开、议案审议程序符合法律、行政法规、部门规章、规 范性文件和《公司章程》的规定。 （二）会议出席情况 会议应出席董事 7 人，出席和授权出席董事 7 人。 二、议案审议 ...

Financial Performance - Operating revenue increased by 32.22% to ¥68,344,387.65, driven by higher sales of aerospace and semiconductor products[13] - Net profit attributable to shareholders decreased by 23.91% to ¥4,822,512.18, compared to the same period last year[11] - Total operating revenue for Q1 2025 reached ¥68,344,387.65, an increase from ¥51,690,492.50 in Q1 2024, representing a growth of approximately 32.1%[36] - The company's net profit for Q1 2025 was CNY 2,358,958.38, an increase of 24.2% compared to CNY 1,898,362.24 in Q1 2024[40] - Operating revenue for Q1 2025 reached CNY 57,518,720.60, up 42.1% from CNY 40,508,010.26 in Q1 2024[40] - The total comprehensive income for Q1 2025 was CNY 2,358,958.38, compared to CNY 1,898,362.24 in Q1 2024, reflecting a growth of 24.2%[41] Cash Flow and Liquidity - Cash flow from operating activities showed a significant decline of 118.72%, resulting in a net outflow of ¥1,158,115.82[13] - The company's cash and cash equivalents decreased to ¥23,975,993.76 as of March 31, 2025, down from ¥48,530,242.30 at the end of 2024, a decline of approximately 50.6%[33] - Cash inflow from investment activities totaled 11,500.00, significantly lower than 39,739,006.41 in the previous year[45] - Cash outflow for investment activities was 4,241,646.00, compared to 40,000,000.00 in Q1 2024, indicating a reduction in investment spending[45] - The net cash increase for the period was -24,554,248.54, contrasting with a positive increase of 13,038,541.01 in Q1 2024[45] Assets and Liabilities - Total assets decreased by 7.38% to ¥420,151,660.92 compared to the end of the previous year[11] - The company's current assets totaled RMB 248,143,628.72, down from RMB 280,318,354.53, indicating a decrease of about 11.5%[30] - Total liabilities decreased to RMB 65,096,261.23 from RMB 103,676,207.12, a significant reduction of about 37.2%[32] - The total liabilities decreased to ¥41,323,190.25 as of March 31, 2025, from ¥65,061,847.14 at the end of 2024, a significant decline of about 36.5%[34] Shareholder Information - The total number of ordinary shareholders was 5,480, with total share capital remaining at 72,700,000 shares[17] - Shanghai Awei Special Enterprise Development Co., Ltd. holds 62.72% of the shares, totaling 45,600,000 shares[18] - The total number of shares held by the top ten shareholders is 52,114,223, representing 71.68% of the total shares[19] - The total number of shares held by Shanghai Awei Special Enterprise Management Consulting Partnership (Limited Partnership) is 4,800,000, representing 6.60% of the total shares[18] Legal and Compliance - The company has ongoing litigation against Guangjing Shiru Technology (Shenzhen) Co., Ltd. for unpaid goods, with a total claim amount of 1,118,922.27 CNY and 1,792,439.05 CNY in two separate cases[24] - The court ruled that Guangjing Shiru Technology must pay 1,050,175.85 CNY and 1,721,011.45 CNY respectively, along with interest, within ten days of the judgment[24] - The company is in the process of enforcing court judgments against Guangjing Shiru Technology for non-compliance with payment orders[25] - The company has not engaged in any external guarantees or loans during the reporting period[23] - The company has timely disclosed all major related transactions and commitments as required[23] Operational Efficiency - The company's cash and cash equivalents were RMB 63,985,265.12, compared to RMB 72,407,313.39 at the end of 2024, representing a decline of approximately 11.6%[30] - Accounts receivable decreased to RMB 65,893,672.72 from RMB 75,008,198.27, a reduction of about 12.2%[30] - Inventory levels dropped to RMB 84,139,858.16 from RMB 98,715,906.98, reflecting a decrease of approximately 14.7%[30] - Research and development expenses for Q1 2025 were ¥3,662,262.76, a decrease from ¥4,554,405.90 in Q1 2024, representing a decline of about 19.6%[36] - The company reported a decrease in research and development expenses to CNY 1,946,306.62 in Q1 2025 from CNY 2,513,055.38 in Q1 2024, a reduction of 22.5%[40]

一、主要会计数据和财务指标 二、前10名无限售条件股东持股情况 数据四舍五入，查看更多财务数据>> | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | 0.0700 | 0.0900 | -22.22 | 0.1100 | | 每股净资产（元） | 4.87 | 4.65 | 4.73 | 4.8 | | 每股公积金(元) | 2.11 | 2.08 | 1.44 | 1.64 | | 每股未分配利润(元) | 1.59 | 1.40 | 13.57 | 1.97 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 0.68 | 0.52 | 30.77 | 0.54 | | 净利润(亿元) | 0.05 | 0.06 | -16.67 | 0.07 | | 净资产收益率(%) | 1.37 | 1.88 | -27.13 | 2.27 | 前十大流通股东累计持有： 1602.43万股，累计占流通股比： 43.77%，较 ...